20 patients in what less than 12months better than their expectations......wow. That can only mean one thing. Clinicians are pushing their patients toward this trial.. get ready for another rerate in a share price.
Ann: Completion of recruitment to paxalisib P2 GBM study, page-2
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)